{
    "clinical_study": {
        "@rank": "161264", 
        "arm_group": {
            "arm_group_label": "IgG4-RD", 
            "description": "Patients with IgG4-RD, including sclerosing pancreatitis, sclerosing cholangitis, inflammatory pseudotumors, retroperitoneal or mediastinal fibrosis, interstitial nephritis, hypophysitis, sclerosing dacryoadenitis, sialadenitis (Mikulicz disease and K\u00fcttner's tumor), inflammatory aortic aneurysm, lymphadenopathy, or other inflammatory conditions."
        }, 
        "biospec_descr": {
            "textblock": "blood samples (serum and plasma, with DNA)"
        }, 
        "biospec_retention": "Samples With DNA", 
        "brief_summary": {
            "textblock": "This is an cohort study to investigate the disease course and treatment response of patients\n      with IgG4-related disease."
        }, 
        "brief_title": "Cohort Study of IgG4RD", 
        "completion_date": {
            "#text": "March 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "IgG4-related Disease", 
        "detailed_description": {
            "textblock": "Immunoglobulin G4-related disease (IgG4-RD) is a recently defined emerging clinical entity\n      characterized by tissue infiltration by IgG4-positive plasma cells, tissue fibrosclerosis\n      and elevated serum IgG4 concentration.\n\n      In this study, patients with IgG4-RD will be investigated, including clinical presentation,\n      laboratory findings and imaging study. All patients will be treated by standard care and\n      follow-uped for at least 6 months."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Males and females\n\n          -  Age 18-75 years old with informed consent\n\n          -  Patients with IgG4-RD:\n\n               1. swelling, sclerosing and inflammatory involvement of one or more organ,\n                  including sclerosing pancreatitis, sclerosing cholangitis, inflammatory\n                  pseudotumors, retroperitoneal or mediastinal fibrosis, interstitial nephritis,\n                  hypophysitis, sclerosing dacryoadenitis, sialadenitis, inflammatory aortic\n                  aneurysm, lymphadenopathy, or other inflammatory conditions;\n\n               2. elevated serum IgG4 (>1.35 g/L)\n\n               3. histopathologic features of fibrosis and/or lymphocytic and polyclonal plasma\n                  cell infiltration (and IgG4+ plasma cells on immunohistology when performed);\n\n               4. exclusion of other diseases.\n\n        Exclusion Criteria:\n\n          -  Females planning to bear a child recently or with childbearing potential\n\n          -  Concurrent severe and/or uncontrolled and/or unstable diseases\n\n          -  Patient with malignancy"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "75 Years", 
            "minimum_age": "18 Years", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "Adult patients with newly diagnosed IgG4-related disease."
            }
        }, 
        "enrollment": {
            "#text": "100", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "August 16, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01670695", 
            "org_study_id": "IgG4RD-Cohort"
        }, 
        "intervention_browse": {
            "mesh_term": "Immunoglobulin G"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "IgG4-related disease", 
            "IgG4-RD"
        ], 
        "lastchanged_date": "August 20, 2012", 
        "location": {
            "contact": {
                "email": "zhangwen91@sina.com", 
                "last_name": "Wen Zhang, MD", 
                "phone": "86-10-69158795"
            }, 
            "contact_backup": {
                "email": "chen77hua@gmail.com", 
                "last_name": "Hua Chen, MD", 
                "phone": "86-10-69158797"
            }, 
            "facility": {
                "address": {
                    "city": "Beijing", 
                    "country": "China", 
                    "state": "Beijing", 
                    "zip": "100032"
                }, 
                "name": "Deptment of Rheumatology, Peking Union Medical College Hospital"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "China"
        }, 
        "number_of_groups": "1", 
        "official_title": "Cohort Study of Patients With IgG4-Related Disease", 
        "overall_contact": {
            "email": "chen77hua@gmail.com", 
            "last_name": "Hua Chen, MD", 
            "phone": "86-10-69158797"
        }, 
        "overall_official": [
            {
                "affiliation": "Deptment of Rheumatology, Peking Union Medical College Hospital", 
                "last_name": "Wen Zhang, MD", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Deptment of Rheumatology, Peking Union Medical College Hospital", 
                "last_name": "Fengchun Zhang", 
                "role": "Study Chair"
            }
        ], 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "China: National Natural Science Foundation", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 0", 
        "primary_completion_date": {
            "#text": "January 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Clinical Response is measured by IgG4-RD Responder Index, including organ/site score and serum IgG4 level.", 
            "measure": "Clinical Response", 
            "safety_issue": "No", 
            "time_frame": "6 months"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01670695"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Peking Union Medical College Hospital", 
            "investigator_full_name": "Wen Zhang", 
            "investigator_title": "Professor", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "source": "Peking Union Medical College Hospital", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Peking Union Medical College Hospital", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "August 2012", 
        "study_design": "Observational Model: Cohort, Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "August 2012"
    }
}